Slawomir Ziegert

SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore.

Biopartners GmbH engages in the development of biopharmaceutical products in the fields of endocrinology, multiple sclerosis, and virology. The company was founded in 2000 and is headquartered in Baar, Switzerland.

Egis Gyógyszergyár Zrt. engages in the manufacture, trade, and distribution of pharmaceutical products. It offers drugs, tablets, injections, and galenic formulations. The company was founded by Sándor Balla and Albert Wander in 1913 and is headquartered in Budapest, Hungary.

Ipsen Poland Sp zoo engages in the research and development in the area of pharmaceutics. It develops cancer, endocrinology, and neurological treatments. The company was founded in 1993 and is headquartered in Warsaw, Poland.

Eli Lilly Polska Sp zoo engages in the medical research and drug production. It offers medicinal products used in treatment of diabetes, cancer, heart diseases, erectile dysfunction, and mental disorders. The company was founded in 1977 and is headquartered in Warsaw, Poland.